| |
Mammalian
glutamate dehydrogenase (GDH) is a mitochondrial enzyme that catalyzes
the reversible oxidative deamination of L-glutamate to 2-oxoglutarate
using NAD(P)+ as coenzyme. The enzyme is a homohexamer that is
tightly regulated by a large number of positive and negative allosteric
effectors as well as by cooperative interactions between subunits.
|
Structure:
|
| The Figure to
the right is a ribbon diagram of the entire boGDH
hexamer. In this diagram, each of the identical subunits are
represented by different colors. The N-terminal GLU binding
domain forms all of the interactions across the non-crystallographic
2-fold axes. The NAD+ binding domain rests on top of the GLU
binding domain giving the subunit a ‘clam-like’ appearance with the
active site lying in the cleft between the two domains. The NAD+
binding domain makes very little contact with the other subunits in the
hexamer. In contrast, the antenna region, extending from the top
of the NAD+ binding domain, forms extensive interactions with other
subunits in the trimers. The long helix is quite amphipathic with
a large number of leucines and valines contacting the other helices
that form this right-handed helical bundle. This large,
48-residue antenna region is not found in non-mammalian GDH and may be
intimately involved in allosteric regulation. |
 |
Regulation:
|
|
We have
determined the structures of several structures of both bovine and
human GDH in the presence of a number of ligands. Shown on the
right is one of the 6 subunits colored from red to blue as the chain
extends from the N to the C terminus. The yellow, grey, red, and
green sphere models are glutamate, NAD, GTP, and ADP,
respectively. During each catalytic turnover, the entire NAD
binding domain moves up and down by ~20° as the enzyme clamps down
on the substrate and then opens it to release the produces. We
propose that GTP acts as an inhibitor by binding to the side of the
mouth after it closes down on substrates and prevents the enzyme from
opening its mouth to release product. Conversely, we argue that
ADP binds to either the open or closed forms of the enzyme and
facilitates the motion during catalysis. During this cycle, the
antennae undergo a great deal of conformational change - which we argue
is necessary for regulation.
|
 |
Evolution:
|
|
It was long
thought that only GDH from the animal kingdom was regulated by a number
of allosteric ligands and that the unusual antenna region was also only
found in animal GDH. Animal GDH is inhibited by GTP, ATP, and
palmatoyl CoA and activated by leucine and ADP. However, recent
sequencing of tetrahymena and paramecium GDH clearly demonstrated that
the antenna evolved first in these protists. Upon analysis of the
enzymes it was found that tetrahymena GDH was regulated by palmatoyl
CoA and ADP but not GTP, ATP, or leucine. When the antenna was
genetically removed, the enzyme lost much of this regulation. As
noted below, GTP and leucine regulate GDH that in turn affects insulin
secretion. Therefore, we suggested that animal GDH regulation is
a result of evolutionary exaptation. The protists evolved the
antenna for regulation as fatty acid oxidation was moving from the
peroxisomes to the mitochondria. The regulation afforded by the
antenna allowed them to link fatty acid and amino acid oxidation.
Animals then used this feature and further evolved it to also control
insulin homeostasis.
|
 |
Insulin:
|
|
|
Although the
allosteric regulation of GDH has been intensively studied, its role in
human physiology has remained unclear until recent demonstration of the
involvement of GDH in a newly discovered form of congenital
hypoglycemia; hyperinsulinism and hyperammonemia (HI / HA)
syndrome. In some children, however,
hyperinsulinism is also associated with hyperammonemia. Patients
were found to be heterozygous for mutant forms
of GDH that were unresponsive to the inhibitor, GTP. In the
beta cells of the pancreas, the increased glutamate to a-ketoglutarate
conversion will increase respiration rate via the Krebs cycle, increase
the ATP/ADP ratio, leading to inhibition of K+ channel activity, and
result in excessive release of insulin. This may also explain why
these patients are particularly sensitive to protein-induced
hypoglycemia. Leucine is an activator of GDH
and therefore ingestion of protein could exacerbate the already
hyperactive state of GDH.
Shown here is the location of the HI/HA mutants with respect
to the bound GTP inhibitor. Most mutations directly interact with
GTP but some mutations are on the portion of the antenna that moves as
the mouth opens and closes.
|
 |
A cup of Tea:
|
|
Our goal was to find a non-toxic pharmacological agent that could be
used to test these models and access whether GDH might be an
appropriate target in the treatment of insulin disorders. To that
end, naturally occurring compounds from green tea were examined.
According to legend, green tea was discovered by the Chinese Emperor
Shen-Nung in 2737 B.C. and for centuries has been used as a folk remedy
to treat a number of ailments including diabetes mellitus. Green
tea is a significant source of a type of flavonoids called catechins;
including epigallocatechin gallate (EGCG), epigallocatechin (EGC),
epicatechin gallate (ECG), and epicatechin (EC). One 200 ml cup
of green tea supplies 140, 65, 28, and 17 mg of these polyphenols,
respectively.
We
found that EGCG specifically and allosterically inhibits GDH and, in
turn, affects insulin secretion by pancreatic ß-cells.
Kinetic
analysis demonstrates that EGCG and ECG, but not EGC and EC, inhibit
purified GDH with nanomolar ED50’s. This inhibition is dependent
upon
the antenna-like protrusion on the enzyme but is unlikely to bind to
the GTP inhibitory site since EGCG inhibits forms of GDH with
non-functional GTP sites. In-situ studies with pancreatic
ß-cells
demonstrated that EGCG specifically affects insulin secretion under
conditions where GDH is known important for insulin homeostasis.
These
results demonstrate that EGCG can be used a pharmacological tool to
examine the complex regulation of insulin secretion by specifically
blocking GDH activity.
|
 |
| |
| |
| |
[Return to top]
|